Your browser doesn't support javascript.
loading
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis.
Etemadifar, Masoud; Abhari, Amir Parsa; Nouri, Hosein; Sigari, Amirhossein Akhavan; Piran Daliyeh, Seyed Mohammad; Maracy, Mohammad Reza; Salari, Mehri; Maleki, Shiva; Sedaghat, Nahad.
Affiliation
  • Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Abhari AP; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Nouri H; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Sigari AA; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Iran.
  • Piran Daliyeh SM; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Maracy MR; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Iran.
  • Salari M; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Maleki S; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Sedaghat N; Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Hum Vaccin Immunother ; 18(1): 2041945, 2022 12 31.
Article de En | MEDLINE | ID: mdl-35201963
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Sclérose en plaques Type d'étude: Prognostic_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Hum Vaccin Immunother Année: 2022 Type de document: Article Pays d'affiliation: Iran Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Sclérose en plaques Type d'étude: Prognostic_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Hum Vaccin Immunother Année: 2022 Type de document: Article Pays d'affiliation: Iran Pays de publication: États-Unis d'Amérique